Presentation is loading. Please wait.

Presentation is loading. Please wait.

Michael Weaver, MD, FASAM Division of Addiction Psychiatry Virginia Commonwealth University Medical Center 2010 Health Summit Substance Abuse and Pregnancy.

Similar presentations


Presentation on theme: "Michael Weaver, MD, FASAM Division of Addiction Psychiatry Virginia Commonwealth University Medical Center 2010 Health Summit Substance Abuse and Pregnancy."— Presentation transcript:

1 Michael Weaver, MD, FASAM Division of Addiction Psychiatry Virginia Commonwealth University Medical Center 2010 Health Summit Substance Abuse and Pregnancy Charlottesville, Virginia

2  Substance use and pregnancy  Maternal & fetal effects during pregnancy  Addiction treatment during pregnancy  Neonatal Abstinence Syndrome  Home environment

3  Risk-taking behavior while intoxicated  Unprotected sex may lead to pregnancy  Drug use causes irregular menstrual cycles, but can still conceive  May not realize she is pregnant for several months

4  Prostitution  Sex for money to pay for drugs  “Trading favors” – sex for drugs  Consensual transaction  Impaired judgment while in “drug den”  Unsafe sex  Not always able to use a condom  Risk of HIV, Hepatitis B & C, other sexually transmitted diseases  Risk of violence, fear of prosecution

5  May be physical, mental, or social  Due to  Side effects of drug  Isolation (prefer drug to socialization)  Cost of obtaining (especially on Black Market)  Unknown adulterants  Route of administration (injection)

6  Co-occurring mental health and substance abuse diagnoses  Anxiety  Depression  Schizophrenia  Personality disorders  Cognitive-behavioral counseling more challenging  Best success with treatment of both conditions simultaneously

7  Higher risk for substance use among those with any psychiatric disorder  Contact with health care or criminal justice system is opportunity to intervene  Earlier detection and intervention prevents problems  Screening is not universal

8  Substance abuse can masquerade as almost any psychiatric symptom  Drug-induced psychiatric symptoms improve markedly over 2-4 weeks following abstinence  Risk of suicide among substance dependent patients  up to 10 times higher than in the general population

9  Sedative- hypnotics  Opioids  Stimulants  Nicotine  Marijuana

10  CNS depressant  Disinhibition  depress inhibitions first  Reduce anxiety (fun at parties)  Oversedation, ataxia, respiratory depression  Daily drinking leads to tolerance and withdrawal  Delirium tremens

11  Benzodiazepines, barbiturates, other sleeping pills (Ambien, Lunesta)  Sedation, anxiolytic  Respiratory depression in overdose  Withdrawal similar to alcohol DT’s

12  Common to both:  Restlessness  Insomnia  Nausea/vomiting  High blood pressure  Rapid heart rate  Rapid breathing  Seizures  Seen in withdrawal, but not pregnancy:  Distractibility  Impaired memory  Agitation  Tremor  Fever  Sweating  Hallucinations

13  Withdrawal symptoms may be life-threatening to mother and fetus  Acute withdrawal treatment should be accomplished in an inpatient setting  Risk to mother/fetus of untreated withdrawal is greater than risk from exposure to medications in a controlled setting

14  Fetal Alcohol Syndrome  Fetal Alcohol Effects  Spectrum disorder  Leading preventable cause of mental retardation  Encourage abstinence as soon as pregnancy suspected

15  Morphine, heroin, OxyContin, methadone  Analgesics: disconnect from pain  Euphoria, disconnection, sedation  Nausea, constipation, itching  Oversedation, respiratory depression

16  No known fetal anomalies  Intrauterine growth retardation  Neonatal abstinence syndrome  Continuous exposure  Use up to delivery

17  Cocaine, amphetamine, methylphenidate, MDMA (Ecstasy), caffeine  Enhanced concentration, alertness  Edginess, paranoia, hypervigilance, psychosis  Hypertension, hyperthermia, vasoconstriction  Heart attack, stroke

18  Spontaneous abortion  Placental abruption  Fetal hypertension  Intrauterine growth retardation  SIDS  ‘Crack baby syndrome’ disproven

19  Cigarettes, cigars, pipes, “snuff,” “chew”  Stimulant & relaxes  Acute effects  Vasoconstriction   secretions  Chronic effects  Lung disease, heart disease  Cancer  Very short-acting, so high-frequency use  Very reinforcing

20  craving for tobacco  irritability, frustration, anger  anxiety  difficulty concentrating  restlessness  decreased heart rate  increased appetite or weight gain  depression  disrupted sleep  sedation

21  Most common fetal exposure  Intrauterine growth retardation  Higher rates of spontaneous abortion, placenta previa, etc.  SIDS risk >4x higher  Nicotine patch better than smoking cigarettes

22  Marijuana, hashish, hash oil  active ingredient: THC  relaxation, hallucination  panic attacks  short-term memory impairment, amnesia

23  Intrauterine growth retardation  Abnormal startle reflexes in newborns  Reduced memory & verbal skills at age 4 years

24  White powder  Varies dealer to dealer & batch to batch  “Buyer beware”  Common adulterants  Sugar, condensed milk  OTC or Rx meds  Causes problems when fetus exposed during pregnancy

25  All pregnant women should be screened for drug and alcohol use  T-ACE: emphasizes tolerance over guilt  A positive screen indicates the need for further evaluation

26  Alienation from family  Multiple jobs  Financial problems  Multiple arrests  Multiple partners  Loss of custody

27  Continued substance use despite adverse consequences  Use in larger amounts or for longer periods than intended  Preoccupation with acquiring or using  Inability to cut down, stop, or stay stopped, resulting in a relapse  Use of multiple substances of abuse

28 High-risk Obstetrics Clinic – Screening, evaluation Team approach in hospital setting – Certified Addictions Nurse – Clinical Social Worker – Obstetrics/Pediatrics Continuity after hospitalization – Healthy Start Initiative through Community Services Board Medical management of withdrawal Motivational interviewing approach Linkage to resources in community Good professional relationships – Child Protective Services – Criminal Justice System

29  Detoxification  12-Step groups  Outpatient counseling  Intensive outpatient  Inpatient  Residential  Opioid Maintenance  Methadone  Buprenorphine

30  Women wary of acknowledging problem  Fear of legal consequences (loss of custody)  Reporting requirements  Public health authorities, child protective services  Criminal justice system  When identified or at time of delivery  Inform patient of legal obligation

31 Sustained remission rates of up to 60% – Better success than treatment of hypertension, diabetes Every $1 spent on treatment saves $7 in costs to society Lots of new research

32  High rates of non- adherence to pharmacotherapy  Careful monitoring of adherence  Long-acting preparations may be beneficial for severe chronic mental illness  Some psychiatric meds can be problematic in pregnancy  Weigh risks vs. benefits

33  A.A., N.A., C.A.  Group format  Anonymous  No cost  No affiliations or endorsement  Different groups have different characteristics

34  Motivational Interviewing  Motivate the patient to reduce/stop drinking and/or seek further treatment  Cognitive-Behavioral Treatment  Identify life stressors, high-risk situations for drinking, and coping skills deficits  Use modeling and rehearsal  Relapse Prevention  Identify triggers, practice avoiding, emphasize responsibility  A ‘slip’ is a learning opportunity

35  Network therapy  Family therapy  Supportive psychotherapy  Contingency management  Building Social networks  Twelve-Step facilitation  Perceptual Adjustment therapy  Rational Recovery  Medication management  Brief intervention

36  Non-hospital therapeutic environment  May include 12-step groups  Consistency in message conveyed by staff  Ideal elements for pregnant addicted women  Childcare (for older children)  Coordination with obstetric care

37  Long-acting medication in controlled setting  Counseling  Social services  Avoid withdrawal & craving  Reduce disease & crime  Maintenance vs. detoxification

38  Long-acting pure opioid agonist  Available for opioid addiction treatment only in federally licensed programs  Requires daily clinic visits, but may get take-home dose privileges  Significant street reputation  Also used for pain like other Schedule II opioids

39  Standard of care for opioid-dependent pregnant women  Stabilization of mother and fetus  Medical and social  Higher dose in 3 rd trimester  Improves growth of fetus & newborn  Decreases practice of high-risk behaviors

40  Long-acting opioid agonist-antagonist  Office-based opioid addiction treatment  Schedule III  Buy at local pharmacy (Subutex, Suboxone)  Very low risk of overdose  Combined with naloxone  Used for acute pain treatment (Buprenex)

41  Pregnancy Category C  Use Subutex instead of Suboxone to avoid naloxone  NAS less intense than with methadone  Studies ongoing, results encouraging

42  Characterized by  Hyperactivity, irritable  Hypertonia  Difficulty/excessive sucking  High-pitched cries  Begins 3h to 12d after delivery, depending on drugs used by mother

43  Initial treatment is supportive  Swaddling, frequent feeding, IV fluids  Assess regularly for symptoms and failure to thrive  Pharmacotherapy  Usually opioids, occasionally sedative-hypnotic  Tincture of opium, paregoric, methadone, phenobarbital

44  Addicted pregnant woman often product of poor parenting  Support network for new mother  Family, 12-Step group, health care workers  Encourage involvement of significant other  Lack of support can lead to relapse  Social services may need to be notified of unsafe living conditions

45  Education  Breastfeeding  Umbilical cord care  Approach for ‘fussy’ infant  Age-appropriate discipline for other children  Prevent frustration that leads to relapse

46  Encouraged  Promote bonding  Optimal nutrition  Passive immunity  Contraindications  Active substance abuse  HIV +  Methadone or buprenorphine dose not important consideration

47 Young children don’t have to use drugs themselves to be affected – Child neglect & abuse – Loss of family structure – Inappropriate role models Impair intellectual, social, & ethical behavior

48  Drug use behaviors may increase risk for unplanned pregnancy  Nicotine replacement is preferable to smoking during pregnancy  Fetal Alcohol Syndrome is the leading preventable cause of mental retardation  Alcohol and sedative withdrawal should be treated in an inpatient setting  Adulterants also harm mother and fetus

49  Most common obstetrical effect of illicit drugs is low birthweight  Methadone maintenance is treatment of choice for opioid-addicted pregnant women  Breastfeeding is encouraged (as long as not actively using illicit drugs or alcohol)  Support for mother is essential  Anticipate and educate to prevent relapse

50


Download ppt "Michael Weaver, MD, FASAM Division of Addiction Psychiatry Virginia Commonwealth University Medical Center 2010 Health Summit Substance Abuse and Pregnancy."

Similar presentations


Ads by Google